Zhang, Yu <br/><br/>
Pyk2 promotes tumor progression in multiple myeloma.  [electronic resource] 

 -  Blood  Oct 2014 
 - 2675-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2014-03-563981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopyridines--pharmacology<br/>Animals<br/>Cell Adhesion--drug effects<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Disease Progression<br/>Female<br/>Focal Adhesion Kinase 2--antagonists & inhibitors<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Green Fluorescent Proteins--genetics<br/>HEK293 Cells<br/>Humans<br/>Immunoblotting<br/>Luminescent Measurements<br/>Mice, SCID<br/>Multiple Myeloma--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>RNA Interference<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Survival Analysis<br/>Tumor Burden--drug effects<br/>Wnt Signaling Pathway--drug effects<br/>Xenograft Model Antitumor Assays<br/>beta Catenin--metabolism